News
Directorate Change
11 June 2013
The Board of TyraTech (AIM: TYR and TYRU), a life sciences company focusing on natural pest control and healthcare products, announces that Dr. Kevin Shultz retired from the Company and resigned from the Board as a Non-Executive Director with effect from 1 April 2013.
Commenting, Alan Reade, Executive Chairman of the Company said: "Kevin was of great assistance in guiding the Company through a challenging period in its growth, firstly as the Head of Research and Development and latterly as a Non-Executive Director. The Board members would like to record their gratitude for the contribution made and wish Kevin well for the future".
For further information please contact:
| TyraTech Inc. Alan Reade, Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +1 919 415 4310 Tel: +1 919 415 4280 |
| N+1 Singer, Nominated Adviser and Joint Broker Aubrey Powell / Alex Wright |
Tel: +44 20 7496 3000 |
| First Columbus LLP, Joint Broker Chris Crawford |
Tel: +44 20 3002 2070 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.